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Abstract
Background—Maternal metabolic demands change dramatically during the course of gestation 
and must be coordinated with the needs of the developing placenta and fetus. The liver is critically 
involved in metabolism and other important functions. However, maternal hepatic adjustments to 
pregnancy are poorly understood.
Aim—The aim of the study was to evaluate the influences of pregnancy on the maternal liver 
growth and gene expression profile.
Methods—Holtzman Sprague-Dawley rats were mated and sacrificed at various stages of 
gestation and postpartum. The maternal Livers were analyzed in gravimetric response, DNA 
content by PicoGreen dsDNA quantitation reagent, hepatocyte ploidy by flow cytometry, and 
hepatocyte proliferation by ki-67 immunostaining. Gene expression profiling of nonpregnant and 
gestation d18.5 maternal hepatic tissue was analyzed using a DNA microarray approach and 
partially verified by northern blot or quantitative real-time PCR analysis.
Results—During pregnancy, the liver exhibited approximately an 80% increase in size; 
proportional to the increase in body weight of the pregnant animals. The pregnancy-induced 
hepatomegaly was a physiological event of liver growth manifested by increases in maternal 
hepatic DNA content and hepatocyte proliferation. Pregnancy did not affect hepatocyte 
polyploidization. Pegnancy-dependent changes in hepatic expression were noted for a number of 
genes, including those associated with cell proliferation, cytokine signaling, liver regeneration, 
and metabolism.
Conclusions—The metabolic demands of pregnancy cause marked adjustments in maternal 
liver physiology. Central to these adjustments are an expansion in hepatic capacity and changes in 
hepatic gene expression. Our findings provide insights into pregnancy-dependent hepatic 
adaptations.
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Introduction
During pregnancy, a series of coordinated physiological adaptations occur in many maternal 
organ systems, including hyperplasia of beta cell mass in pancreatic islets required for 
elevated production of insulin (1), splenic growth and development of the erythroid lineage 
(2), forebrain olfactory neurogenesis associated with maternal behaviors (3), immune system 
adjustments to protect the fetal-maternal interface from immunological attack (4), increased 
blood volume and cardiac output to meet the needs of fetal-maternal bio-exchange of gas, 
nutrients, and metabolic wastes (5). These widespread maternal physiological changes are 
highly coordinated with the development and growth of the placenta and fetus and are 
essential for successful establishment and maintenance of pregnancy.
Maternal metabolic demands change dramatically during the course of gestation. The liver is 
critically involved in metabolism and a variety of physiological functions involving the 
uptake, storage and distribution of both nutrients and vitamins, maintenance of blood sugar 
levels, regulation of circulating plasma lipids, the synthesis of circulating plasma proteins 
and metabolism of nutrients, toxic compounds, and drugs. During pregnancy, it is 
anticipated that the liver would increase its functional capacity to accommodate the 
nutritional and metabolic needs of developing placentas and fetuses. Several lines of 
evidence indicate the functional adjustments of the maternal liver to pregnancy, such as 
pregnancy-dependent changes in drug, lipid, cholesterol, and glucose metabolism (6-13). 
These adjustments are associated with the alterations of metabolic enzyme activity, nuclear 
receptor expression, and gonadal and pituitary hormone signaling in the maternal liver 
during pregnancy (13-17). Notably, it has been observed that maternal liver weight increases 
during pregnancy in the mouse and rat (7, 10, 14, 18). However, the impact of pregnancy on 
maternal liver weight has not been systematically evaluated. In this investigation, we 
examined hepatic adaptations to pregnancy at organ, cellular, and molecular levels.
Materials and methods
Animals and tissue preparation
Holtzman Sprague-Dawley rats (8 weeks of age) were obtained from Harlan Sprague 
Dawley Inc. (Indianapolis, IN). The presence of sperm in the vaginal smear of the rat was 
considered to be gestational d0.5. Animals were provided food and water ad libitum. 
Animals were placed on a 12 h light:12 h dark cycle and the temperature and relative 
humidity were maintained between 20-24°C and 40-60%, respectively. Liver tissue was 
collected from non-pregnant (n=7), gestational d4.5 (n=4), d8.5 (n=7), d11.5 (n=13), d13.5 
(n=13), d15.5 (n=5), d18.5 (n=7), d20.5 (n=7), d21.5 (n=5) and postpartum d10 with and 
without pups (n=5 and n=7, respectively) rats and weighed. The body weights of non-
pregnant rats, pregnant rats with conceptuses, and postpartum d10 rats were recorded. All 
collected tissues were then snap-frozen in liquid nitrogen and stored at -80°C. Animal care 
and experimental protocols were approved by The University of Kansas Medical Center 
Animal Care and Use Committee.
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DNA content
Liver tissues collected from non-pregnant, pregnant (gestation d11.5 and d18.5) and 
postpartum d10 (with and without pups) rats were completely digested overnight at 55°C in 
a buffer containing 100 mM NaCl, 50 mM Tris-HCl (pH 8.0), 25 mM EDTA, 0.5% SDS 
and 400μg/ml of proteinase K (n=3 per group). The digested samples were mixed with 
PicoGreen dsDNA quantitation reagent (Molecular Probes, Eugene, OR). The mixed 
samples were excited at 485 nm and the fluorescence emission intensity was measured at 
538 nm using a spectrofluorometer (Finstruments Fluorokan II, MTX Lab System, Inc., 
Vienna, VA). DNA concentrations were determined using a standard curve of fluorescence 
emission intensity plotted versus DNA concentration. The standard curve was generated 
with the reagents provided by the vendor.
Ki-67 immunostaining
Liver tissues were collected from nonpregnant, pregnant (gestational d4.5, d8.5, d11.5, 
d13.5, d15.5, d18.5, and d21.5), and postpartum d10 non-lactating and lactating rats. 
Formalin-fixed and paraffin-embedded liver tissue sections were prepared and subjected to 
Ki-67 immunostaining with a primary Ki-67 antibody (NeoMarkers, Fremont, CA) 
according to the manufacturer's instructions. This procedure was used to monitor hepatocyte 
proliferation in the liver.
Hepatocyte isolation and ploidy analysis
Primary rat hepatocytes were isolated using the procedure described by Kim and coworkers 
(19). Rats were anesthetized before in situ perfusion of the liver through the portal vein with 
Hanks Balanced Salt Solution followed by Gibco Liver Digestion Medium (Invitrogen, 
Carlsbad, CA). RPMI1640 with supplements (10% fetal bovine serum, FBS, 100 U/ml 
penicillin, 100 μg/ml streptomycin) was added to the dissociated hepatoctyes. Hepatocytes 
were passed through sterile gauze and isolated by centrifugation. Trypan blue was used to 
determine cell viability which exceeded 80%. Propidium iodide staining was performed 
using 2 × 106 cells/ml. Hepatocytes were resuspended in 1 ml of 0.9% sodium chloride and 
fixed by adding 2.5 ml of 90% cold ethanol. Following a 30 min incubation at room 
temperature, cells were centrifuged at 50 ×g for 2 min and the pellet was resuspended in 1 
ml of propidium iodide (50 μg/ml in phosphate buffered saline, pH 7.2). In addition, 100 μl 
of Rnase A (1 mg/ml) was added to the cells and incubated for 30 min at 37°C. Hepatocytes 
were analyzed by flow cytometry using BD LSRII and FACS Diva (BD Biosciences, San 
Jose, CA).
Microarray analysis
Total RNA was prepared from liver tissue of non-pregnant (n=9) and gestation d18.5 (n=9) 
using TRIzol reagent according to the manufacturer's protocol (Invitrogen, Carlsbard, CA). 
RNA extractions were pooled to form three groups of three livers for each collection day in 
nuclease-free water at a concentration of 1.0 μg/μl. The Affymetrix GeneChip system was 
used to process GeneChip expression arrays (Affymetrix, Santa Clara, CA) and performed 
by the University of Kansas Medical Center Microarray Facility. Reverse transcription (RT) 
utilizing 5 μg total RNA was conducted using the SuperScript Choice System (Invitrogen). 
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The RT was driven by the annealing of an oligo dT primer coupled with a T7 promoter 
sequence. The resulting cDNA was labeled with biotin using the GeneChip Expression 3′ 
Amplification reagent kit (Affymetrix). Biotin labeled cRNA was then fragmented with 
Mg++ and K+ at high temperature to a size range of ∼50-200 bp. Biotin-labeled fragmented 
cRNAs were hybridized to the Rat 230.20 GeneChip Expression array (Affymetrix) for 16 h 
at 45°C and 60 rpm in a GeneChip Hybridization Oven 640 (Affymetrix). Hybridized 
GeneChips underwent low and high stringency washing and R-phycoerythrin-streptavidin 
staining procedures using a GeneChip Fluidics Station (Affymetrix). GeneChips were 
scanned using a Genechip scanner 3000 7G with autoloader. Fluidics and scan functions 
were controlled by GCOS software version 1.4. Expression data sets were analyzed using 
the expression analysis software GeneSpring 7.0.
Cloning
cDNAs for the genes listed in Table 1 were isolated by RT-PCR from total RNA extracts 
prepared with TRIzol reagent from either non-pregnant or gestation d18.5 rat livers. Five μg 
of total RNA and 0.5 μg of oligo dT were used for reverse transcription reactions with 
Superscript II RT (Invitrogen). PCR was performed using Platinium Taq DNA High Fidelity 
polymerase (Invitrogen) with specific primers (Table 1). PCR was conducted for 30 cycles 
under the following conditions; preheat, 94°, denature 94° for 1 min, anneal, 60° for 1 min, 
extension, 72° for 1 min. PCR products were separated on 1% agarose gels and stained with 
ethidium bromide. Amplified products were subcloned into pCRII-TOPO vector with the 
TOPO TA Cloning kit (Invitrogen). cDNAs were sequenced by the Northwestern University 
DNA Sequencing Center (Chicago, IL).
Northern analysis
Northern blotting was conducted as previously described (20). RNA was extracted from 
tissues using TRIzol. Total RNA (20 μg) was separated on 1% formaldehyde-agarose gels 
and transferred to nylon membranes. Blots were probed with [32P]-labeled cDNAs indicated 
in Table 1. G3pdh cDNA was used as an internal control to demonstrate equal loading and 
RNA integrity.
Quantitative RT-PCR (qRT-PCR)
cDNAs were synthesized with total RNA (1 μg) from each sample using M-MLV reverse 
transcriptase (Invitrogen), diluted 5 times with water, and subjected to SYBR qRT-PCR to 
quantify mRNA levels of the genes listed in Table 2. Primers (Table 2) were designed using 
Primer Express 2.0 (Applied Biosystems, Foster City, CA). Real-time PCR amplification of 
cDNAs was carried out in a reaction mixture (10 μl) containing SYBR GREEN PCR Master 
Mix (Applied Biosystems) and primers (600 nM each). Amplification and fluorescence 
detection were carried out using the ABI Prism 7500 Real Time PCR System (Applied 
Biosystems). Cycling conditions included an initial hold step (95 °C for 10 min) and 40 
cycles of a 2-step PCR (92 °C for 15 s, then 60 °C for 1 min), followed by a dissociation 
step (95 °C for 15 s, 60 °C for 15 s, and then 95 °C for 15 s). The comparative CT method 
was used for relative quantification of the amount of mRNA for each sample normalized to 
18S RNA.
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Statistical analysis
The data were analyzed by analysis of variance and post hoc comparisons determined by 
Newman-Keuls Test. Data analysis of hepatocyte ploidy was analyzed by comparing means 
using the two-tailed Student's t-test.
Results
Pregnancy induces maternal hepatomegaly
Holtzman Sprague-Dawley rats were mated and sacrificed at various stages of gestation and 
postpartum. Gravimetric responses of maternal livers were assessed throughout pregnancy 
and postpartum (d10) in non-lactating and lactating conditions. Significant increases in 
maternal liver weight were observed during pregnancy (Fig. 1A&B). In comparison with 
pre-pregnancy liver sizes, pregnancy-dependent increases in liver mass were statistically 
significant at gestation d8.5 and sustained thereafter, culminating in about an 80% liver 
enlargement (hepatomegaly). Pregnant and nonpregnant rats did not significantly differ in 
liver-to-body weight ratios (Fig. 1C). The observation indicates that the maternal liver 
adjusts its size proportionally to the collective increases in maternal body weight and the 
weights of the placentas and fetuses. Following parturition, the maternal liver regressed at 
d10 postpartum in the non-lactating condition, whereas the maternal liver retained its pre-
partum sizes in the lactating condition. In summary, we have identified an adaptive response 
of the maternal liver to pregnancy and lactation.
Pregnancy-induced hepatomegaly is associated with increases in hepatic DNA content 
and hepatocyte proliferation
In order to determine the cellular basis underlying pregnancy-dependent liver weight 
increases, we first measured the total DNA content in the livers of nonpregnant rats, 
pregnant rats (gestation d11.5 and d18.5), and at d10 postpartum in both non-lactating and 
lactating rats. During pregnancy, liver DNA content was significantly increased on gestation 
d18.5 as compared with nonpregnant rats (Fig. 2). Following parturition, lactating rats 
possessed higher liver DNA content than non-lactating rats (Fig. 2). Pregnancy and lactation 
associated-increases in liver size correlated with increases in DNA content.
A significant number of hepatocytes routinely undergo endoreduplication generating large 
polyploid cells (21). Hepatocyte polyploidization has been associated with many 
physiological and pathological processes (22). It is unknown whether pregnancy alters 
hepatocyte endoreduplication and whether this might impact liver DNA content and growth. 
Thus, we determined the impact of pregnancy on hepatocyte DNA content. Primary 
hepatocytes were isolated from the livers of nonpregnant and gestation d18.5 rats, stained 
with propidium iodide, and subjected to flow cytometry analysis. Livers from pregnant and 
nonpregnant rats did not differ in their contents of diploid (2N), tetraploid (4N), and 
octoploid (8N) hepatocytes (Fig. 3). The data indicate that pregnancy does not exert a 
significant affect on hepatocyte polyploidization.
Ki-67 immunostaining on tissue sections prepared from livers of nonpregnant, pregnant, and 
postpartum rats were performed to further assess the impact of pregnancy and lactation on 
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hepatocyte proliferation. A gestation-dependent increase in the number of Ki-67-positive 
hepatocytes was observed (Fig. 4). Maternal hepatocyte proliferation occurred before 
implantation (gestation d4.5), continued through midgestation, peaked at gestation d18.5, 
and subsequently arrested just prior to parturition. Postpartum liver samples did not exhibit 
evidence of hepatocyte proliferation (Fig. 4). The data indicate that maternal hepatocytes 
undergo replication throughout most of gestation.
Pregnancy alters maternal hepatic gene expression
To identify potential regulators of pregnancy-dependent liver growth, gene expression 
profiling of nonpregnant and gestation d18.5 maternal hepatic tissue was analyzed using a 
DNA microarray approach. Genes exhibiting at least a four-fold upregulation or 
downregulation in mRNA expression (pregnant versus nonpregnant) are listed in Tables 3 
and 4. Verification of the changes in hepatic transcript levels of these genes was extended to 
the entire course of pregnancy and postpartum by northern blot or qRT-PCR analysis (Fig. 
5). Genes exhibiting at least a 2.5-fold but less than 4-fold upregulation or downregulation 
in mRNA expression (pregnant versus nonpregnant) are listed in Supplemental Tables 1 and 
2.
Genes upregulated in the liver during pregnancy exhibited distinct expression patterns (Fig. 
5). Hepatic mRNA expression of nephroblastoma overexpressed gene (Nov/Ccn3), 
transcription factor mammalian achaete-scute homolog-1 (Ascl1), patatin-like phospholipase 
domain-containing protein 3 (Pnpla3), neurotrophic tyrosine kinase receptor type 1 (Ntrk1), 
transcription factor early growth response-1 (Egr1), and a cell surface protein prominin 1 
(Prom1) increased as pregnancy advanced, especially during the second half of pregnancy in 
parallel with increases in maternal liver growth. Hepatic alpha-2 macroglobulin (A2m) 
transcript levels were prominently elevated at the end of pregnancy, coincident with the 
arrest of maternal hepatocyte proliferation (Fig. 4). mRNA for TNF receptor super family 
member 9 (Tnfrsf9) exhibited continued increases in hepatic expression throughout the 
course of pregnancy. Insulin-like growth factor binding protein 1 (Igfbp1) gene expression 
was highly dynamic. Igfbp1 mRNA decreased at gestation d4.5, rebounded to pre-pregnancy 
levels at gestation d8.5 and d11.5, decreased again at gestation days d13.5, and d15.5, and 
showed a dramatic upregulation prior to parturition (gestation d18.5 and d21.5).
Hepatic downregulation of several regulatory genes were verified by northern blotting or 
qRT-PCR analyses (Fig. 5). Hepcidin antimicrobial peptide (Hamp), protein phosphatase 1 
regulatory subunit 3C (Ppp1r3c), and monocyte to macrophage differentiation-associated 2 
(Mmd2) mRNAs declined as pregnancy progressed, inversely related to maternal liver 
growth. Tumor-associated calcium signal transducer 1 (Tacstd1) transcripts levels were 
elevated during the first half of gestation and declined during the second half of gestation.
Following parturition, expression levels for most genes investigated, including Ccn3, A2m, 
Ascl1, Ntrk1, Prom1, Hamp, Tacstd1, and Ppp1r3c, returned to pre-pregnancy levels in 
livers from both non-lactating and lactating rats (Fig. 5). The data suggest that this subset of 
genes is regulated in the liver by pregnancy, irrespective of postpartum events. However, the 
remainder of the tested genes was modulated by both pregnancy and lactation in hepatic 
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expression. Lactation stimulated hepatic expression of Egr1, Pnpla3, Igfbp1, and Tnfrsf9 
mRNA and inhibited Mmd2 transcript levels (Fig. 5).
Collectively, we demonstrate that the maternal liver adapts to pregnancy by altering its gene 
expression profile. Genes exhibiting robust pregnancy-dependent changes in maternal 
hepatic expression have been identified, providing us with a molecular basis for further 
investigation of the regulation of liver physiology during pregnancy. Pregnancy and 
lactation exert distinct effects on hepatic gene expression.
Discussion
The current study identified a robust growth response of the maternal liver to pregnancy, 
which was characterized by marked increases in maternal hepatic DNA content, hepatocyte 
proliferation, and increases in liver size. Lactation sustained pregnancy-dependent liver 
growth. Pregnancy represents a relatively unexplored model system to investigate the 
regulation of hepatocyte proliferation and liver remodeling. Reduction of liver mass by 
partial hepatectomy, a most commonly used model in the study of liver regeneration (23), 
induces intra- and/or extra-hepatic production of a variety of cytokines and growth factors, 
which coordinately stimulate liver cell proliferation and tissue remodeling (23, 24). 
Production of interleukin-6 and tumor necrosis factor alpha and activation of urokinase, 
Notch, β-catenin, signal transducer and activator of transcription protein 3, nuclear factor-
kappa B, c-fos, c-jun, hepatocyte growth factor receptor, and epidermal growth factor 
receptor are among the preparative events for the entry of hepatocytes into the cell cycle. 
Concomitant with or subsequent to those early responses are the production of direct 
mitogens, including hepatocyte growth factor and transforming growth factor alpha, and 
comitogens, such as tumor necrosis factor and norepinephrine. These factors render the 
hepatocytes to enter into and progress through the cell cycle. As a consequence, the lost liver 
mass is restored by liver re-growth. Whether or not the factors involved in liver regeneration 
participate in modulating pregnancy-induced liver growth is under our investigation. 
Additionally, estrogen enhances the mitogenic effect of growth factors and therefore is 
classified as a comitogen for hepatocytes (25, 26). In vivo studies showed that estrogen 
induces transient hepatocyte proliferation and liver growth (27-29). It is evident that 
estrogen receptor is involved in the regulation of liver regeneration (29-32). Therefore, 
estrogen receptor signaling should be included in the future mechanistic study on 
pregnancy-induced liver growth.
Pregnancy induced maternal hepatocyte proliferation without affecting hepatocyte 
endoreduplication, an important feature of liver growth and physiology. Advanced 
polyploidy in mammalian cells is indicative of terminal differentiation and senescence (22, 
33, 34), leading to a progressive loss of cell pluripotency and decreased replication capacity 
(35). The biological significance of hepatic polyploidy remains unclear (36). It has been 
suggested that the polyploid genome may provide protection against the dominant 
expression of mutated oncogenes for an organ heavily engaged in drug detoxification (37). 
Another suggestion is that hepatocyte endoreduplication is a normal process that occurs in 
response to oxidative stress and helps to maintain the detoxification capacity without having 
to proliferate (21). Remarkably, liver polyploidization is differentially regulated in two 
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models of liver growth:i) following loss of liver mass; ii) liver tumor development. Ploidy of 
liver cells increases during liver re-growth induced by partial hepatectomy and results in an 
attenuation of proliferative capacity (38), whereas, hepatocellular tumor growth shifts to a 
nonpolyploidizing growth pattern manifested by expansion of the diploid hepatocyte 
population (39, 40). Our study revealed a distinct liver growth pattern, which exhibits 
massive hepatocyte proliferation without an alteration of polypoidization. This might be a 
unique feature of pregnancy-dependent liver growth.
Concomitant to its size adjustment to pregnancy, the maternal liver exhibits changes in its 
gene expression profile. Among the genes showing robust gestation-dependent increases in 
maternal hepatic expression were Ccn3, Ascl1, Ntrk1, Egr1, Tnfrsf9, Prom1, A2m, and 
Pnpla3. In contrast, Mmd2, Hamp, and Ppplr3c displayed marked gestation-dependent 
decreases in maternal hepatic expression. More complex pregnancy-dependent expression 
patterns were evident for Igfbp1 and Tacstd1. Some of these genes have been implicated in 
processes that may contribute to the regulation of pregnancy-dependent liver adaptations and 
more specifically to the control of hepatocyte proliferation and hepatic remodeling (see 
Supplemental Discussion).
In summary, as pregnancy advances, maternal hepatocytes exhibit an increased rate of 
proliferation without an increase in endoreduplication. The outcome is growth of the 
maternal liver proportional to increases in maternal body weight. It is presumed that these 
maternal hepatic adaptations are directed to meeting the needs of the mother and promoting 
growth of the placentas and fetuses. The maternal liver also changes its gene expression 
profile in response to pregnancy. Some of the differentially expressed genes may represent 
components of regulatory pathways controlling hepatic adaptations. Pregnancy-dependent 
growth of the maternal liver represents a physiologically-relevant model system for 
investigating the regulation of hepatocyte proliferation and hepatic remodeling.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Abbrevations
A2M alpha-2 macroglobulin
Ascl1 mammalian achaete-scute homolog-1
Egr1 early growth response-1
Hamp hepcidin antimicrobial peptide
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Igfbp1 insulin-like growth factor binding protein 1
Mmd2 monocyte to macrophage differentiation-associated 2
NOV nephroblastoma overexpressed gene
Ntrk1 neurotrophic tyrosine kinase receptor type 1
Pnpla3 patatin-like phospholipase domain-containing protein 3
Ppp1r3c protein phosphatase 1 regulatory subunit 3
Tacstd1 tumor-associated calcium signal transducer 1
Tnfrsf9 TNF receptor super family member 9
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Fig. 1. Maternal liver weight responses to pregnancy and lactation in the rat
Tissues were collected from non-pregnant (np), pregnant (gestational d4.5, d8.5, d11.5, 
d13.5, d15.5, d18.5, and d21.5), and postpartum d10 non-lactating (nlac) and lactating (lac) 
rats and weighed. Maternal liver weight responses are shown in Panel A. Representative 
gross morphology of nonpregnant (NP) and gestation d18.5 livers is shown in Panel B. 
Liver weight responses were also normalized to body weight as shown in Panel C. Asterisks 
indicate values that are significantly different from values for non-pregnant animals (P < 
0.05; n = 5 to 7).
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Fig. 2. Measurement of liver DNA content from non-pregnant, pregnant, and post-partum rats
Liver tissues collected from non-pregnant (np), pregnant (gestational d11.5 and d18.5) and 
postpartum d10 non-lactating (nlc) and lactating (lac) rats were completely digested 
overnight. DNA content was measured using Quant-iT PicoGreen dsDNA Kit. DNA 
concentrations were determined using a standard curve of fluorescence emission intensity 
plotted versus DNA concentration. Asterisks indicate values that are significantly different 
from values for non-pregnant animals (P < 0.05; n = 5 to 7).
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Fig. 3. Hepatocyte ploidy analysis
Primary rat hepatocytes were isolated from non-pregnant (np) and gestational d18.5 animals 
and stained with propidium iodide. Hepatocyte ploidy (2N, 4N, and 8N) was analyzed by 
flow cytometry using BD LSRII and FACS Diva. Histograms from the flow cytometry are 
shown in Panel A. Populations of hepatocytes with different DNA contents are shown in 
Panel B.
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Fig. 4. Ki-67 immunostaining in liver tissues
Liver tissues were collected from nonpregnant (NP), pregnant (gestational d4.5, d8.5, d11.5, 
d13.5, d15.5, d18.5, and d21.5), and postpartum d10 non-lactating (nlac) and lactating (lac) 
rats. The tissues were fixed in formalin and embedded in paraffin. Liver tissue sections were 
prepared and Ki-67 immunostaining was performed. The nuclei of Ki67-positive cells 
stained dark brown. (A) Representative liver sections immunohistochemically stained for 
Ki-67 are shown for NP and gestation d18.5 rats. (B) Ki67-positive hepatocytes were 
counted (40 × optical field) and the results are shown as mean number of positive nuclei per 
field ± SD. Asterisks indicate values that are significantly different from values for non-
pregnant animals (P < 0.05; n = 3).
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Fig. 5. Hepatic gene expression during pregnancy and lactation in the rat
Total RNA was prepared from liver tissue of non-pregnant (np), pregnant (gestational d4.5, 
d8.5, d11.5, d13.5, d15.5, d18.5, and d21.5), and postpartum d10 non-lactating (nlac) and 
lactating (lac) rats. (A) The expression of indicated genes was analyzed by northern blotting. 
G3PDH served as control for loading and RNA integrity. (B) Maternal hepatic mRNA levels 
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of indicated genes were assessed by quantitative RT-PCR and are expressed as means of 
fold changes compared to nonpregnant controls ± SD (n = 3 for each group). *, P < 0.05.
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Table 1
PCR Primer Sequences
Gene Symbol GenBank Primer Sequence (5′ to 3′)
Alpha-2 macroglobulin A2m NM_012488 Fwd GAAGAGTCCGTGGCTTTCTG
Rev TAGCAGGCGTTGCTATCCTT
Patatin-like phospholipase domain containing 3 Pnpla3 XM_343302 Fwd TTCTACCACATCGGGGCTAC
Rev CGGAAGGAAGGAGGGATTAG
Nephroblastoma overexpressed gene Nov NM_030868 Fwd ACCTGTGGCTCAGAGGAGAA
Rev CCCTGGCAAACACTGAAACT
Early growth response 1 Egr1 NM_012551 Fwd CCACAACAACAGGGAGACCT
Rev TCTTGCGTTCATCACTCCTG
Hepcidin antimicrobial peptide Hamp NM_053469 Fwd ACAGAAGGCAAGATGGCACT
Rev TGCAACAGAGACCACAGGAG
Insulin-like growth factor binding protein 1 Igfbp1 NM_013144 Fwd CAGCAAACAGTGCGAGACAT
Rev CTGCCCTTTCAAAGCAGAAC
Neurotrophic tyrosine kinase, receptor, type 1 Ntrk1 NM_021589 Fwd TACCTAGCCAGCCTGCACTT
Rev TCCAGACTCCTAGCCCAGAA
Achaete-scute complex homolog-like 1 Ascl1 NM_022384 Fwd GGCTCAACTTCAGTGGCTTC
Rev ACACAGGATCTCCTGCCATC
Prominin 1 Prom1 NM_021751 Fwd GCAAAAGAGGTCGAGGAGTG
Rev GCAGAATCCAAAGAGGCAAG
Glyceraldehyde-3-phosphate dehydrogenase G3pdh NM_017008 Fwd ACCACAGTCCATGCCATCAC
Rev TCCACCACCCTGTTGCTGTA
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Table 2
qRT-PCR Primer Sequences
Gene Symbol GenBank Primer Sequence (5′ to 3′)
Tumor necrosis factor receptor superfamily, member 9 
(CD137, ILA, 4-1BB)
Tnfrsf9 AI_236084 Fwd ACTTTCTGCAGTAAATACCCTC
Rev GAACCTGAAATAGCCTTGACAC
Tumor-associated calcium signal transducer 1 Tacstd1 BG_376410 Fwd GTCCTTGTTCCATTCATCTAAGAG
Rev CCATCTCCTTTATCTCAGCC
Monocyte to macrophage differentiation-associated 2 Mmd2 BI_296275 Fwd GTGATTTACTTCTTCATTGCGG
Rev AAGCTTGTACCGTTCATGGA
Protein phosphatase 1, regulatory subunit 3C Ppp1r3c BM_390827 Fwd GGTCCTTACAATGGTCTTCAG
Rev CATTCCTTCTGTGATTTGGCT
18s rRNA 18s rRNA M11188 Fwd GCAATTATTCCCCATGAACG
Rev GGCCTCACTAAACCATCCAA
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Table 3
Selected genes exhibiting increased hepatic expression in pregnant rats
Gene Symbol Ratio* Functional group
Nephroblastoma overexpressed gene Nov 81.9 Ligand-signaling
Alpha 2-macroglobulin A2m 32.7 Acute phase protein
Early growth response 1 Egr1 15.2 Transcriptional regulation
Patatin-like phospholipase domain containing 3 Pnpla3 6.4 Lipid metabolism
Neurotrophic tyrosine kinase, receptor, type 1 Ntrk1 4.8 Ligand receptor-signaling (neural)
Achaete-scute complex homolog-like 1 Ascl1 4.7 Transcriptional regulation (neural)
Insulin-like growth factor binding protein 1 Igfbp1 4.6 Ligand transport
Similar to hypothetical protein – MGC13251 RGD1308350 4.5 Unknown
Tumor necrosis factor receptor superfamily, member 9 (CD137, ILA, 4-1BB) Tnfrsf9 4.4 Ligand receptor-signaling
Prominin 1 Prom1 4.2 Stem cell surface protein
*
Pregnant:non-pregnant
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Table 4
Selected genes exhibiting decreased hepatic expression in pregnant rats
Gene Symbol Ratio* Functional group
Unknown Est --------- 0.05 Unknown
Tumor-associated calcium signal transducer 1 Tacstd1 0.14 Epithelial cell adhesion molecule
Cytochrome P450, 3a18 Cyp3a18 0.16 Metabolic enzyme
Flavin containing monoxygenase 1 Fmo1 0.19 Metabolic enzyme
Hepcidin antimicrobial peptide Hamp 0.21 iron metabolism and inflammation
X-prolyl aminopeptidase 2, membrane bound Xpnpep2 0.21 Prolidase
Sulfotransferase family, cytosolic, 1C, member 2 Sult1c2 0.22 Metabolic enzyme
Protein phosphatase 1, regulatory subunit 3C Ppp1r3c 0.22 Glycogen metabolism
Monocyte to macrophage differentiation-associated 2 Mmd2 0.23 Membrane receptor
Glucokinase Gck 0.24 Insulin signaling
Glutamic pyruvic transaminase 1, soluble Gpt1 0.25 Biosynthetic enzyme
Carbonic anhydrase 3 Ca3 0.25 Nitrogen metabolism
*
Pregnant:non-pregnant
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